Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Convertible Debt (2022 - 2025)

Historic Convertible Debt for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • Coeptis Therapeutics Holdings' Convertible Debt changed N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $218750.0 for FY2024, which is 6500.0% down from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Convertible Debt stood at $1.1 million.
  • In the past 5 years, Coeptis Therapeutics Holdings' Convertible Debt ranged from a high of $1.3 million in Q2 2025 and a low of $58100.0 during Q3 2022
  • Moreover, its 4-year median value for Convertible Debt was $218750.0 (2024), whereas its average is $518336.9.
  • Examining YoY changes over the last 5 years, Coeptis Therapeutics Holdings' Convertible Debt showed a top increase of 6500.0% in 2024 and a maximum decrease of 6500.0% in 2024.
  • Over the past 4 years, Coeptis Therapeutics Holdings' Convertible Debt (Quarter) stood at $58100.0 in 2022, then skyrocketed by 975.73% to $625000.0 in 2023, then crashed by 65.0% to $218750.0 in 2024, then surged by 402.86% to $1.1 million in 2025.
  • Its Convertible Debt was $1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and $218750.0 in Q1 2025.